Committed to sharing our science

Committed to sharing our science

405 results available

Favorable Effect of Aficamten on Left Atrial Mechanics in Obstructive Hypertrophic Cardiomyopathy: Insights from the SEQUOIA-HCM Trial

Oral Presentation, ESC-HFA 2026

Hamatani, Y et al.

May 9, 2026
No Increase in Arrhythmia Burden Following Aficamten Treatment in Obstructive Hypertrophic Cardiomyopathy: Extended Ambulatory Electrocardiogram Analysis From FOREST-HCM

Poster, ESC-HFA 2026

Rowin, EJ et al.

May 11, 2026
Efficacy of Aficamten in Hypertrophic Cardiomyopathy Patients With Very-High Left Ventricular Outflow Tract Gradients

The American Journal of Cardiology

Veselka, J et al.

April 17, 2026
Serum Magnesium and Outcomes in Heart Failure With Reduced Ejection Fraction: The GALACTIC-HF Trial

European Heart Journal

Chimura, M et al.

August 31, 2025
Evaluation of Aficamten or Beta-Blocker Monotherapy Versus Placebo in Patients with Obstructive Hypertrophic Cardiomyopathy: A Pooled Analysis of SEQUOIA-HCM and MAPLE-HCM

Poster, ACC 2026

Schulze, PC et al.

March 30, 2026